ATHALTERITY THERAPEUTICS LIMITEDMarket sensitive

Alterity and FDA Agree on Phase 3 Program for ATH434 in MSA

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFATH announcement history

Recent ATH announcements